SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Select Medical Holdings Corporation was acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe for $16.50 per share (approximately $3.9 billion enterprise value) pursuant to a Merger Agreement dated March 2, 2026. The merger became effective on July 1, 2026, resulting in a change of control, conversion of all outstanding shares to cash consideration, and delisting from NYSE.
View raw filing on EDGAR →The filing discloses the declaration of a quarterly dividend of $0.190 per share payable on July 17, 2026, to common stockholders of record on July 13, 2026. This is a routine but material dividend distribution announcement for a REIT, which typically distributes substantial portions of taxable income to shareholders on a quarterly basis. The disclosure clearly identifies the per-share amount, payment date, and record date.
View raw filing on EDGAR →Richmond Mutual Bancorporation completed its merger with The Farmers Bancorp effective July 1, 2026, with Richmond as the surviving corporation. Farmers shareholders received 3.40 shares of Richmond common stock per Farmers share, resulting in the issuance of approximately 6.25 million shares.
View raw filing on EDGAR →This exhibit is a press release announcing Biophytis's provisional, unaudited financial results for fiscal year 2025, including net loss of €7.8 million, cash position of €190 thousand, and a going-concern disclosure. While the results are presented as "provisional" pending audit completion, the disclosure of annual financial results, material uncertainty regarding going concern, and strategic updates constitute a material earnings announcement that would affect a reasonable investor's assessment of the company's financial condition and viability.
View raw filing on EDGAR →The filing discloses the outcome of the Company's annual meeting of stockholders held on July 1, 2026. Although the specific vote results are not detailed, the material fact disclosed is that the meeting failed to achieve quorum and was adjourned to July 30, 2026. This is a shareholder vote matter under Item 5.07, and the failure to achieve quorum at an annual meeting is material to investors as it affects governance proceedings and the timing of shareholder actions.
View raw filing on EDGAR →This Item 5.07 disclosure presents the complete results of Hyperion DeFi's 2026 Annual Meeting of Stockholders held on June 30, 2026, including voting outcomes on five proposals: election of five directors, ratification of auditors (CBIZ CPAs P.C.), advisory approval of named executive officer compensation, approval of an amended certificate of incorporation (which failed), and approval of meeting adjournment authority. The filing explicitly states "The results of the proposals at the Annual Meeting are set forth below," making this a textbook shareholder vote results disclosure material to investors assessing governance and board composition.
View raw filing on EDGAR →Arbor Realty Trust priced a $325 million offering of 6.25% Convertible Senior Notes due 2029 in a private placement to qualified institutional buyers on June 30, 2026. This is a material creation of a new direct financial obligation. While the filing also discloses concurrent share repurchases and a prepaid forward transaction, the primary disclosed event is the debt issuance itself, which is the core capital-raising activity and creates the principal new obligation.
View raw filing on EDGAR →QXO completed its acquisition of TopBuild Corp. on July 1, 2026, for approximately $6.4 billion in cash and 312.5 million QXO shares, making TopBuild a wholly owned subsidiary. The transaction significantly expands QXO's scale and capabilities across the building products value chain, with expected annual synergies of at least $300 million by 2030 and anticipated accretion to earnings.
View raw filing on EDGAR →QXO appointed Alec Covington as a director effective upon completion of the TopBuild Merger and appointed Madeline Otero as Interim Chief Accounting Officer effective July 1, 2026, with specified compensation including $400k base salary, $600k equity target, and $500k retention award.
View raw filing on EDGAR →NN Inc. entered into a Securities Purchase Agreement on June 30, 2026, to sell 24,509,804 shares of common stock in a private placement at $3.06 per share, generating $75.0 million in gross proceeds. The unregistered private placement under Section 4(a)(2) of the Securities Act and Regulation D is material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →Cumberland Pharmaceuticals completed the sale of its branded pharmaceutical business to Apotex and affiliates for $100 million in cash on July 1, 2026, following shareholder approval on June 24, 2026 with 99% support. The transaction fundamentally restructures the company to focus on its rare disease pipeline, eliminating substantially all revenue-generating operations. Amendment No. 1 to the acquisition agreement excluded certain contracts from the transferred assets, and the related credit facility was terminated upon closing.
View raw filing on EDGAR →The disclosure centers on John Vong's appointment as Senior Vice President – Accounting and his succession to the principal accounting officer role effective August 7, 2026, following Glenn Sobotka's retirement. While both a departure and appointment occur, the filing emphasizes Vong's appointment and qualifications, making the appointment the principal disclosed action. The change in the principal accounting officer is material to investors assessing the company's financial reporting oversight.
View raw filing on EDGAR →QXO completed its acquisition of TopBuild on July 1, 2026, pursuant to a two-step merger structure (Titanium Merger and Forward Merger), with merger consideration of $505.00 cash or 20.200 QXO shares per TopBuild share, and 91% of shareholders electing cash. The transaction includes $6.0 billion+ in new financing arrangements (term loans, secured notes, and ABL facility) and results in TopBuild becoming a QXO subsidiary.
View raw filing on EDGAR →In connection with the TopBuild acquisition, QXO entered into material definitive agreements creating $6.0 billion+ in new direct financial obligations, including a $3.0 billion incremental term loan, $3.0 billion in secured notes, and a $2.0 billion ABL facility, while simultaneously terminating TopBuild's prior credit agreement and purchasing/redeeming substantially all of TopBuild's outstanding senior notes (2029, 2032, and 2034 maturities).
View raw filing on EDGAR →TopBuild's common stock (ticker BLD) was delisted from NYSE effective July 1, 2026, following completion of the merger with QXO; NYSE filed Form 25 to initiate deregistration under Section 12(b) of the Exchange Act, and TopBuild intends to file Form 15 to deregister under Section 12(g) and suspend reporting obligations.
View raw filing on EDGAR →Joseph M. Viselli, a named executive officer of TopBuild, voluntarily resigned from his employment on June 30, 2026, following his retirement, and received severance compensation of $894,539 in cash.
View raw filing on EDGAR →The exhibit announces completion of a strategic acquisition of 16 NVIDIA Blackwell B300 AI servers for US$1.0 million in cash and US$10.0 million in equity, closed June 28, 2026. The press release explicitly states this transaction "materially strengthens our balance sheet" and represents "an important milestone in both its strategic expansion into AI computing infrastructure." The acquisition is material to the registrant's financial position and strategic direction, satisfying the M&A activity classification under Item 1.01 / 2.01 equivalent disclosure.
View raw filing on EDGAR →Jackson Financial entered into a $1.25 billion Revolving Credit Agreement on June 30, 2026, with Wells Fargo as Administrative Agent, replacing its prior $1 billion facility. The agreement includes customary financial maintenance covenants and extends the company's borrowing capacity.
View raw filing on EDGAR →Uwe Breitweg, Vice President Powertrain, Emission and Battery Strategy of the BMW Group, was appointed as a Class III director of Solid Power effective July 1, 2026, pursuant to BMW Holding's director nomination rights. The appointment is material given Breitweg's two decades of automotive leadership, deep battery strategy expertise, and BMW's role as a key development partner.
View raw filing on EDGAR →The disclosure describes Sysco's filing of a Form S-4 registration statement in connection with a merger agreement dated March 30, 2026, involving multiple merger subsidiaries and the acquisition of JRD Unico, Inc. and Warehouse Realty, LLC. The Form S-4 contemplates issuance of New Slider HoldCo common stock to Sysco shareholders, indicating a material acquisition or change-of-control transaction requiring SEC registration and shareholder approval.
View raw filing on EDGAR →S&P Global completed the separation of its Mobility division into an independent, publicly-traded company, Mobility Global Inc., through a pro-rata distribution of 100% of Mobility Global shares to S&P Global stockholders effective July 1, 2026. The separation was effected through multiple definitive agreements (Separation and Distribution Agreement, Tax Matters Agreement, Transition Services Agreement, Employee Matters Agreement) and resulted in Mobility Global obtaining its own NYSE listing (MBGL) while S&P Global retained no ownership interest.
View raw filing on EDGAR →Mobility Global Inc. completed its separation from S&P Global Inc. on July 1, 2026, becoming an independent, publicly-traded company. S&P Global distributed 100% of Mobility Global's outstanding common stock to S&P Global shareholders on a 1:1 basis, with Mobility Global commencing trading on the NYSE under ticker MBGL. The separation was governed by multiple definitive agreements including a Separation and Distribution Agreement, Tax Matters Agreement, Transition Services Agreement, and Employee Matters Agreement.
View raw filing on EDGAR →Effective July 1, 2026, Mobility Global appointed a substantially reconstituted board of seven new directors (Eric W. Aboaf, William W. Eager, Heather Lavallee, Monique F. Leroux, Mark S. Peek, Shilpa Ranganathan, and Alexander Taussig), appointed Joseph R. Hinrichs as Chair, and appointed three new officers: Scott Fredericks as President of CARFAX, Joseph S. LaFeir as President of Mobility Business Solutions, and Renato Negro as Chief Accounting Officer. These appointments reflect the company's transition to independent public company status following its separation from S&P Global.
View raw filing on EDGAR →Ares Acquisition Corp III consummated an IPO on July 1, 2026, raising $395 million in gross proceeds and entering into multiple material definitive agreements including underwriting, warrant, trust, and registration rights agreements. The SPAC structure is oriented toward a future business combination.
View raw filing on EDGAR →The Sponsor purchased 7,466,667 warrants at $1.50 per warrant for $11.2 million in proceeds concurrent with the IPO, representing a material private placement of unregistered equity securities.
View raw filing on EDGAR →The disclosure reports stockholder approval and Board implementation of a 1-for-20 reverse stock split, effected through amendments to the Company's Restated Certificate of Incorporation. While a reverse stock split is a governance/capital structure matter rather than a named event type, it is material to investors as it affects share count, ownership percentages, and stock price mechanics. The event is clearly governance-related but does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results (which typically refers to voting on directors or compensation plans rather than capital structure amendments).
View raw filing on EDGAR →IperionX announced receipt of up to US$6.6 million in government funding from the U.S. Department of War's Office of the Secretary of War – Submarine Workforce and Industrial Base program (OSW-SWIB) to scale titanium manufacturing capacity for defense applications, plus a separate purchase order for JLTV fasteners. This is a material operational and strategic milestone—a significant government contract award supporting the company's core business strategy to establish domestic titanium manufacturing for defense customers. While not a discrete M&A transaction, earnings release, or financial obligation, it represents a material operational development that would affect a reasonable investor's assessment of the company's growth prospects and strategic positioning.
View raw filing on EDGAR →The Company announced on June 30, 2026 a planned offering of corporate bonds in Greece with a maximum aggregate nominal amount of €100 million, consisting of up to 100,000 bonds with a five-year term to be admitted to trading on Euronext Athens. This constitutes creation of a new direct financial obligation and falls squarely within debt_issuance. The materiality is clear given the €100 million size and the explicit disclosure in a 6-K filing.
View raw filing on EDGAR →Getty Images' Board unanimously resolved to terminate the Merger Agreement with Shutterstock following the passage of the Second Extended End Date on July 6, 2026, after regulatory conditions imposed by the U.K. CMA required a sale of Shutterstock's editorial business, which Getty Images declined to pursue.
View raw filing on EDGAR →Vishay entered into an underwriting agreement on June 29, 2026 to offer and sell 15,000,000 shares of common stock at $50 per share, with underwriters exercising a 30-day option for an additional 2,250,000 shares on June 30, 2026, generating approximately $830.3 million in net proceeds for growth initiatives and debt reduction.
View raw filing on EDGAR →The filing discloses material progress on a previously announced Business Combination between Valaris and Transocean, specifically the satisfaction of CFIUS approval on June 29, 2026, and ongoing HSR Act review by the DOJ. The transaction involves Transocean acquiring all outstanding Valaris shares at a fixed exchange ratio (15.235 Transocean shares per Valaris share), representing a material change of control event that would materially affect a reasonable investor's assessment of Valaris.
View raw filing on EDGAR →Bed Bath & Beyond completed the acquisition of TwoPonds, Inc. (SFV Services) on June 30, 2026, pursuant to a Merger Agreement, issuing 7.2 million shares of common stock as consideration. The transaction created a wholly owned subsidiary and represents a material change in the company's asset base and strategic direction.
View raw filing on EDGAR →The filing discloses both a director departure (Alexandra Herger's resignation effective July 1, 2026) and a director appointment (John Maxwell appointed to succeed her on the same date). While both events occur, the principal disclosed action centers on the appointment of Maxwell as a director and member of the Nominating and Governance Committee, with nomination for a full 3-year term. The appointment is the forward-looking governance action that materially affects board composition.
View raw filing on EDGAR →The disclosure centers on the Board's approval of a substantial equity grant of 9,099,328 RSUs to each of the two Co-CEOs (William Roberts and Daniel Roberts), subject to a six-year vesting and holding period. This is a compensatory arrangement for named executives under Item 5.02(e), distinct from an appointment or departure. The materiality is evident from the size of the grant, the multi-year vesting structure extending to 2033, and the Board's explicit statement that these grants are designed to retain and incentivize the Co-CEOs and align their interests with shareholders.
View raw filing on EDGAR →Funds managed by Blue Owl Capital completed the acquisition of Sila Realty Trust on July 1, 2026, with all outstanding common stock converted into $30.38 per share in cash (a 19% premium), resulting in delisting from the NYSE and a change of control of the registrant.
View raw filing on EDGAR →Viatris entered into an amended and restated term loan credit agreement on July 1, 2026, providing a ¥40,000,000,000 principal amount senior unsecured term loan facility with a three-year maturity. The facility will be used to repay prior obligations and for general corporate purposes, and includes customary covenants.
View raw filing on EDGAR →The 6-K body references Exhibit 99.1 containing "key updates communicated during 2Q 2026" published on June 30, 2026, and explicitly states that financial results are prepared in accordance with EU IFRS and IASB IFRS. The filing describes financial information and capital objectives based on quarterly results. Although the exhibit itself is not furnished in the body text provided, the explanatory note and structure indicate this is a periodic quarterly financial report disclosure for the second quarter of 2026, not a discrete event announcement.
View raw filing on EDGAR →The 6-K discloses two share buyback programs: completion of a EUR 227 million buyback (33.9 million shares repurchased at EUR 6.68 average price) and initiation of a new EUR 200 million buyback program expected to conclude by December 23, 2026. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution taxonomy. The materiality is evident from the scale (EUR 427 million combined) and the explicit statement that Aegon intends to cancel the repurchased shares, reducing share count and affecting per-share metrics.
View raw filing on EDGAR →The press release announces the declaration of quarterly cash dividends on three series of preferred stock (Series B, C, and D) and common stock. Specific per-share amounts are disclosed for each class ($0.476563, $0.531250, $0.546875 for preferred; $0.125 for common), along with payment and record dates. This is a routine but material dividend declaration typical of dividend-paying companies.
View raw filing on EDGAR →Alvotech announced a $75 million term loan facility amendment to its existing credit agreement with GoldenTree Asset Management and other lenders, bearing 12.50% interest and maturing December 31, 2027. This is a creation of a new direct financial obligation through amendment of a credit facility, which is a classic debt_issuance event. The materiality is clear: the company explicitly states this financing "strengthens Alvotech's financial position" and, combined with the recent $165 million equity raise, provides access to $240 million in new capital to support R&D pipeline execution and global product launches.
View raw filing on EDGAR →Himax announced the proposed disposal of its 31% equity stake in an investee company for US$80 million in cash, with an estimated pre-tax gain of US$23–24 million. This is a material asset sale and divestiture that affects the company's financial position and results, but does not fit the specific categories of M&A activity (which typically involve acquisition or change of control of the registrant itself), debt issuance, or other named financial event types. The transaction is material to investors as it represents a significant capital event and gain realization.
View raw filing on EDGAR →Compass Therapeutics disclosed updated clinical trial data from the COMPANION-002 Phase 2/3 study of its lead candidate tovecimig in biliary tract cancer, showing significant improvements in overall response rate (18.0% vs. 5.3%, p=0.0228) and progression-free survival (4.7 vs. 2.6 months, HR=0.44, p<0.0001). The company announced plans to meet with the FDA and submit a BLA based on these data with potential approval in H2 2027. This represents a material operational/clinical milestone for a development-stage biopharmaceutical company, as the positive Phase 2/3 data and regulatory pathway advancement directly affect the company's near-term value inflection and commercial prospects.
View raw filing on EDGAR →Global-e announced the completion of its acquisition of Passport Global Inc., a US-based cross-border e-commerce logistics company, for $350 million funded via cash and ordinary shares with up to $75 million in contingent consideration. The press release explicitly states "Global-e Online Ltd. (NASDAQ: GLBE)...today announced that it has completed its acquisition of Passport Global Inc." This is a material acquisition that expands Global-e's logistics capabilities and strategic position in cross-border e-commerce.
View raw filing on EDGAR →IM Cannabis announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor. The July Note is convertible into common shares at a price of US$0.152 per share (or 90% of a 20-day VWAP floor), and the company also issued 1,483,386 warrants exercisable at C$0.22. This is a classic dilutive equity issuance—a private placement of convertible securities that will result in the issuance of common shares upon conversion and warrant exercise, materially diluting existing shareholders.
View raw filing on EDGAR →QTREX announced development of a controlled-conductivity cryogenic microwave interconnect architecture and filed a U.S. Provisional Patent Application covering this technology. The disclosure emphasizes the company's vertical integration enabling material-design innovation to address quantum computing's heat-load barrier, with near-term technical evaluation expected from industry collaborators. This is a material operational/strategic milestone—a significant product development and patent filing—but does not fit the discrete event categories (not M&A, not a financial obligation, not litigation, not an executive change). The materiality reflects the company's core quantum-computing focus and claimed competitive advantage, though the forward-looking nature and patent-pending status introduce some uncertainty about ultimate commercial impact.
View raw filing on EDGAR →This is a clear earnings release disclosing financial results for fiscal year ended March 31, 2025. The company issued a press release on June 30, 2026, reporting a net loss of $4.9M on revenues of $9.3M, with detailed consolidated balance sheets and statements of operations attached as Exhibit 99.1. The disclosure includes material financial metrics (gross margin decline of 24 percentage points, operating loss of $2.3M vs. prior year operating income of $737K) and forward-looking guidance, making it material to investors' assessment of the registrant's financial condition.
View raw filing on EDGAR →This press release announces a registered direct offering of 750,000 Class A Ordinary Shares at $1.00 per share, generating approximately $750,000 in gross proceeds. The offering is structured as a registered direct offering (not a public offering) to institutional investors, which is a classic dilutive equity issuance. The disclosure explicitly references the shelf registration statement (Form F-3, File No. 333-291149) and prospectus supplement, confirming this is a registered securities offering that will dilute existing shareholders.
View raw filing on EDGAR →The 6-K furnishes an extraordinary report disclosing the results of voting at Mizuho Financial Group's 24th Ordinary General Meeting of Shareholders held on June 26, 2026. The filing reports the approval of Proposal 1 — the appointment of fourteen directors — with detailed voting tallies (approval, disapproval, abstention) and approval rates for each nominee. This is a classic shareholder_vote_results disclosure under the taxonomy, material because director elections affect governance and investor assessment of the registrant.
View raw filing on EDGAR →This exhibit discloses the results of voting at Honda's 102nd Ordinary General Meeting of Shareholders held on June 26, 2026, specifically the election of eleven directors with detailed vote tallies and approval ratios for each candidate. The document explicitly states it is a "Notice of Submission of Extraordinary Report Relating to Resolutions Passed and Results of Voting" and provides the affirmative votes, negative votes, abstentions, and approval percentages for each director election, meeting the definition of shareholder_vote_results.
View raw filing on EDGAR →The filing discloses a decision by the Compensation Committee to make an additional cash contribution of JPY 2.9 billion to a Board Benefit Trust (BBT) for the purpose of acquiring up to 350,000 shares of the Company for distribution to directors and executive officers under an existing stock compensation program. This is a material compensatory arrangement affecting named executives and directors, falling squarely within exec_compensation disclosure requirements.
View raw filing on EDGAR →